Limited time75% off all plans
Get the app

Obstructive lung diseases (emphysema, bronchitis)

Obstructive lung diseases (emphysema, bronchitis)

Obstructive lung diseases (emphysema, bronchitis)

On this page

Obstructive Lung Disease - The Air-Trapping Intro

Spirometry: Normal, Obstructive, and Restrictive Patterns

  • Defined by airway obstruction causing difficulty with expiration, leading to air trapping.
  • Hallmark on spirometry is a decreased FEV₁/FVC ratio ($< \textbf{0.7}$).
    • Forced Expiratory Volume in 1 sec (FEV₁) is disproportionately ↓.
    • Forced Vital Capacity (FVC) can be normal or ↓.
  • Leads to hyperinflation with ↑ lung volumes:
    • ↑ Total Lung Capacity (TLC)
    • ↑ Functional Residual Capacity (FRC)
    • ↑ Residual Volume (RV)

⭐ While the FEV₁/FVC ratio defines obstruction, the absolute FEV₁ value determines its severity (e.g., GOLD stages for COPD).

Chronic Bronchitis - The Blue Bloater

  • Clinical Dx: Productive cough for >3 months in >2 consecutive years.
  • Pathophysiology: Hypertrophy and hyperplasia of bronchial mucous glands in response to irritants (e.g., smoke).
    • Site: Large airways (bronchi).
    • ↑ Reid index > 0.5 (ratio of gland depth to bronchial wall thickness).
  • Presentation: "Blue Bloater"
    • Early-onset hypoxemia (cyanosis) due to shunting.
    • Hypercapnia, respiratory acidosis.
    • Leads to pulmonary hypertension & cor pulmonale (right heart failure).

⭐ The primary pathology is in the large airways (bronchi), unlike emphysema, which affects the acinus.

Chronic Bronchitis Histopathology

Emphysema - The Pink Puffer

  • Pathogenesis: Permanent enlargement of airspaces distal to terminal bronchioles due to alveolar wall destruction. Caused by ↑ elastase activity.
    • Centriacinar: Smoking-related (most common).
    • Panacinar: α1-antitrypsin (AAT) deficiency.
  • Clinical: "Pink Puffer" → pursed-lip breathing, barrel chest (↑ AP diameter), dyspnea, minimal cyanosis.
  • Diagnosis: PFTs show obstructive pattern: ↓ FEV₁, ↓ FVC, so ↓ $FEV₁/FVC$ ratio (< 0.7). ↑ TLC, ↑ RV. Markedly ↓ DLCO.

⭐ Look for liver cirrhosis in a young, non-smoking patient with emphysema; it suggests AAT deficiency.

COPD Face-Off - Puffer vs. Bloater

Pink Puffer vs. Blue Bloater Clinical Presentations

FeatureEmphysema ("Pink Puffer")Chronic Bronchitis ("Blue Bloater")
PathologyAlveolar wall destruction (↑ elastase).Mucous gland hypertrophy (Reid Index > 0.5).
AppearanceThin, barrel chest, accessory muscle use.Cyanotic, edematous (cor pulmonale).
BreathingPursed-lip breathing, severe dyspnea.Productive cough (>3 mo/yr for >2 yr).
Blood GasPaO₂ ↓, PaCO₂ normal/↓.PaO₂ ↓↓, PaCO₂ ↑↑.
DLCO (↓ surface area).Normal.
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD
subgraph Bronchitis [Chronic Bronchitis]
    B1["<b>🧬 Gland Change</b><br><span style='display:block; text-align:left; color:#555'>• Mucous gland growth</span><span style='display:block; text-align:left; color:#555'>• Wall thickening</span>"]
    B2["<b>💧 Excess Mucus</b><br><span style='display:block; text-align:left; color:#555'>• ⬆️ Sputum production</span><span style='display:block; text-align:left; color:#555'>• Chronic cough</span>"]
    B3["<b>🚫 Obstruction</b><br><span style='display:block; text-align:left; color:#555'>• Airway inflammation</span><span style='display:block; text-align:left; color:#555'>• Narrowed lumen</span>"]
    
    B1 --> B2
    B2 --> B3
end

subgraph Emphysema [Emphysema]
    E1["<b>🔬 Alveolar Damage</b><br><span style='display:block; text-align:left; color:#555'>• Septal destruction</span><span style='display:block; text-align:left; color:#555'>• Large air spaces</span>"]
    E2["<b>🩹 Loss of Recoil</b><br><span style='display:block; text-align:left; color:#555'>• Elastin breakdown</span><span style='display:block; text-align:left; color:#555'>• Floppy airways</span>"]
    E3["<b>🎈 Hyperinflation</b><br><span style='display:block; text-align:left; color:#555'>• ⬆️ Compliance</span><span style='display:block; text-align:left; color:#555'>• Severe air trapping</span>"]
    
    E1 --> E2
    E2 --> E3
end

style B1 fill:#F7F5FD,stroke:#F0EDFA,stroke-width:1.5px,rx:12,ry:12,color:#6B21A8
style B2 fill:#F7F5FD,stroke:#F0EDFA,stroke-width:1.5px,rx:12,ry:12,color:#6B21A8
style B3 fill:#FDF4F3,stroke:#FCE6E4,stroke-width:1.5px,rx:12,ry:12,color:#B91C1C

style E1 fill:#F7F5FD,stroke:#F0EDFA,stroke-width:1.5px,rx:12,ry:12,color:#6B21A8
style E2 fill:#F7F5FD,stroke:#F0EDFA,stroke-width:1.5px,rx:12,ry:12,color:#6B21A8
style E3 fill:#FDF4F3,stroke:#FCE6E4,stroke-width:1.5px,rx:12,ry:12,color:#B91C1C

> ⭐ The diffusing capacity for carbon monoxide (DLCO) is the key differentiating PFT finding. It is **decreased** in emphysema due to destruction of the alveolar-capillary membrane but remains normal in chronic bronchitis.

##  High‑Yield Points - ⚡ Biggest Takeaways

> *   **COPD** presents with **irreversible airflow obstruction**, primarily from **smoking** or **α1-antitrypsin deficiency**.
> *   **Emphysema** ("**Pink Puffer**") features **alveolar destruction**, **↓ elastic recoil**, and a **barrel chest**.
> *   **Chronic Bronchitis** ("**Blue Bloater**") is a clinical diagnosis: **productive cough** for **>3 months** over **2 years**.
> *   Bronchitis pathology shows **submucosal gland hypertrophy**, with an increased **Reid index > 0.4**.
> *   The key diagnostic finding is a **decreased FEV1/FVC ratio (< 0.7)** on spirometry.
> *   Both can lead to **pulmonary hypertension** and **cor pulmonale**.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE